+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioMarin Pharmaceutical Inc. - logo

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.

LAMEA Hemophilia Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Type (Hemophilia A, Hemophilia B), By Treatment Type (Prophylaxis, On-demand, and Cure), By Therapy, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Hemophilia Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Type (Hemophilia A, Hemophilia B), By Treatment Type (Prophylaxis, On-demand, and Cure), By Therapy, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 142 Pages
  • Middle East, Africa
From
Mucopolysaccharidosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Mucopolysaccharidosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • October 2023
  • 150 Pages
  • Global
From
Global Companion Diagnostic Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Companion Diagnostic Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 138 Pages
  • Global
From
Achondroplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Achondroplasia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Companion Diagnostics Market (2nd Edition), 2019-2030 - Product Thumbnail Image

Companion Diagnostics Market (2nd Edition), 2019-2030

  • Report
  • April 2019
  • 300 Pages
  • Global
From
Myotonic Dystrophy Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Myotonic Dystrophy Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 86 Pages
  • Global
From
Dystrophin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Dystrophin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 89 Pages
  • Global
From
State of the Biopharmaceutical Industry 2023 - Product Thumbnail Image

State of the Biopharmaceutical Industry 2023

  • Report
  • December 2022
  • 110 Pages
  • Global
From
Regenerative Medicine in Medical - Thematic Research - Product Thumbnail Image

Regenerative Medicine in Medical - Thematic Research

  • Report
  • July 2022
  • 40 Pages
  • Global
From
Biotechnology Services Global Market Report 2024 - Product Thumbnail Image

Biotechnology Services Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Biotech Ingredient Global Market Report 2024 - Product Thumbnail Image

Biotech Ingredient Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • March 2024
  • 89 Pages
  • Global
From
Firdapse (Amifampridine) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Firdapse (Amifampridine) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 257 Pages
  • Global
From
Batten Disease (BD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Batten Disease (BD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2023
  • 66 Pages
  • Global
From
Achondroplasia Pipeline Analysis 2019 (H1) - Product Thumbnail Image

Achondroplasia Pipeline Analysis 2019 (H1)

  • Report
  • May 2019
  • 82 Pages
  • Global
From
Medical Foods for Inborn Errors of Metabolism Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Age group; Disease; Forms; Packaging; Distribution Channel; and Geography - Product Thumbnail Image

Medical Foods for Inborn Errors of Metabolism Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Age group; Disease; Forms; Packaging; Distribution Channel; and Geography

  • Report
  • June 2020
  • 243 Pages
  • Global
From
Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 87 Pages
  • Global
From
Mucopolysaccharidosis I Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Mucopolysaccharidosis I Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 90 Pages
  • Global
From
Loading Indicator